A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...
The pharma company's shares are getting crushed after regulators decline to green light a drug to treat a rare disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback